Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

HTR1A and HTR2A variants may not predict venlafaxine treatment response in China Han population with major depressive disorder.

Yuan R, Yuan F, Ren D, Zhu Y, Bi Y, Hu J, Guo Z, Xu F, Niu W, Wu X, Cao Y, Yang F, Wang L, Li W, Xu Y, He L, Yu T, He G, Li X.

Psychiatry Res. 2018 Oct 15. pii: S0165-1781(17)32187-X. doi: 10.1016/j.psychres.2018.10.038. [Epub ahead of print] No abstract available.

PMID:
30366640
2.

The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients.

Demirbugen Oz M, Uckun Z, Yuce-Artun N, Baskak B, Ozdemir H, Kizil Ozel T, Devrimci Ozguven H, Suzen HS.

Hum Psychopharmacol. 2018 Sep;33(5):e2673. doi: 10.1002/hup.2673. Epub 2018 Sep 17.

PMID:
30221791
3.

Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample.

Calabrò M, Mandelli L, Crisafulli C, Lee SJ, Jun TY, Wang SM, Patkar AA, Masand PS, Benedetti F, Han C, Pae CU, Serretti A.

Adv Ther. 2018 Oct;35(10):1656-1670. doi: 10.1007/s12325-018-0781-2. Epub 2018 Sep 3.

4.

Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).

Park JY, Lengacher CA, Reich RR, Alinat CB, Ramesar S, Le A, Paterson CL, Pleasant ML, Park HY, Kiluk J, Han H, Ismail-Khan R, Kip KE.

Transl Behav Med. 2018 Aug 20. doi: 10.1093/tbm/iby061. [Epub ahead of print]

PMID:
30137607
5.

Poststroke Depression Biomarkers: A Narrative Review.

Levada OA, Troyan AS.

Front Neurol. 2018 Jul 16;9:577. doi: 10.3389/fneur.2018.00577. eCollection 2018. Review.

6.

Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the HTR2A rs7997012 Polymorphism.

Gassó P, Blázquez A, Rodríguez N, Boloc D, Torres T, Mas S, Lafuente A, Lázaro L.

J Child Adolesc Psychopharmacol. 2018 Jul 5. doi: 10.1089/cap.2018.0004. [Epub ahead of print]

PMID:
29975559
7.

Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools.

Bousman CA, Dunlop BW.

Pharmacogenomics J. 2018 Sep;18(5):613-622. doi: 10.1038/s41397-018-0027-3. Epub 2018 May 25.

PMID:
29795409
8.

Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.

Kitzlerová E, Fišar Z, Lelková P, Jirák R, Zvěřová M, Hroudová J, Manukyan A, Martásek P, Raboch J.

Med Sci Monit. 2018 Apr 28;24:2599-2619. doi: 10.12659/MSM.907202.

9.

Significance of risk polymorphisms for depression depends on stress exposure.

Gonda X, Hullam G, Antal P, Eszlari N, Petschner P, Hökfelt TG, Anderson IM, Deakin JFW, Juhasz G, Bagdy G.

Sci Rep. 2018 Mar 2;8(1):3946. doi: 10.1038/s41598-018-22221-z.

10.

The effect of 5-HTTLPR and a serotonergic multi-marker score on amygdala, prefrontal and anterior cingulate cortex reactivity and habituation in a large, healthy fMRI cohort.

Piel JH, Lett TA, Wackerhagen C, Plichta MM, Mohnke S, Grimm O, Romanczuk-Seiferth N, Degenhardt F, Tost H, Witt S, Nöthen M, Rietschel M, Heinz A, Meyer-Lindenberg A, Walter H, Erk S.

Eur Neuropsychopharmacol. 2018 Mar;28(3):415-427. doi: 10.1016/j.euroneuro.2017.12.014. Epub 2018 Jan 19.

PMID:
29358097
11.

Neural and Genetic Correlates of the Social Sharing of Happiness.

Matsunaga M, Kawamichi H, Umemura T, Hori R, Shibata E, Kobayashi F, Suzuki K, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H, Ohira H.

Front Neurosci. 2017 Dec 19;11:718. doi: 10.3389/fnins.2017.00718. eCollection 2017.

12.

Stress exposure and psychopathology alter methylation of the serotonin receptor 2A (HTR2A) gene in preschoolers.

Parade SH, Novick AM, Parent J, Seifer R, Klaver SJ, Marsit CJ, Gobin AP, Yang BZ, Tyrka AR.

Dev Psychopathol. 2017 Dec;29(5):1619-1626. doi: 10.1017/S0954579417001274.

13.

Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Amare AT, Schubert KO, Baune BT.

EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. Review.

14.

Precision medicine for suicidality: from universality to subtypes and personalization.

Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, Niculescu EM, Niezer JO, Williams A, Graham DL, Jones TJ, Venugopal V, Ballew A, Yard M, Gelbart T, Kurian SM, Shekhar A, Schork NJ, Sandusky GE, Salomon DR.

Mol Psychiatry. 2017 Sep;22(9):1250-1273. doi: 10.1038/mp.2017.128. Epub 2017 Aug 15.

15.

Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients.

Pompili M, Gentile G, Scassellati C, Bonvicini C, Innamorati M, Erbuto D, Montebovi F, Ducci G, Forte A, De Pisa E, Ferracuti S, Serafini G, De Luca V, Amore M, Simmaco M, Girardi P.

Neurosci Lett. 2017 Aug 24;656:94-102. doi: 10.1016/j.neulet.2017.07.020. Epub 2017 Jul 14.

PMID:
28716530
16.

[Serotonergic genes in the development of anxiety/depression-like state and pathology of aggressive behavior in male mice: RNA-seq data].

Kudryavtseva NN, Smagin DA, Kovalenko IL, Galyamina AG, Vishnivetskaya GB, Babenko VN, Orlov YL.

Mol Biol (Mosk). 2017 Mar-Apr;51(2):288-300. doi: 10.7868/S0026898417020136. Russian.

17.

Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.

Health Quality Ontario .

Ont Health Technol Assess Ser. 2017 Apr 11;17(4):1-39. eCollection 2017. Review.

18.

Phf8 loss confers resistance to depression-like and anxiety-like behaviors in mice.

Walsh RM, Shen EY, Bagot RC, Anselmo A, Jiang Y, Javidfar B, Wojtkiewicz GJ, Cloutier J, Chen JW, Sadreyev R, Nestler EJ, Akbarian S, Hochedlinger K.

Nat Commun. 2017 May 9;8:15142. doi: 10.1038/ncomms15142.

19.

Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.

Peterson K, Dieperink E, Anderson J, Boundy E, Ferguson L, Helfand M.

Psychopharmacology (Berl). 2017 Jun;234(11):1649-1661. doi: 10.1007/s00213-017-4622-9. Epub 2017 Apr 29. Review.

PMID:
28456840
20.

Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness.

Amidfar M, Kim YK, Colic L, Arbabi M, Mobaraki G, Hassanzadeh G, Walter M.

Nord J Psychiatry. 2017 May;71(4):282-288. doi: 10.1080/08039488.2016.1276624. Epub 2017 Jan 26.

PMID:
28125323

Supplemental Content

Loading ...
Support Center